Skip to main content

Advertisement

Log in

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma

  • Letter to the editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cordobes MD, Duran M, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumdjian J-C, Prévost G, Caglar M, Moretti J-L. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996; 37:286–289.

    Google Scholar 

  2. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198–2202.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Didier Blocklet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blocklet, D., Schoutens, é., Kentos, A. et al. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med 28, 1432 (2001). https://doi.org/10.1007/s002590100576

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590100576

Navigation